Placebo‐free designs for evaluating new mental health treatments: the use of adaptive treatment strategies
暂无分享,去创建一个
[1] Jacob Cohen,et al. Approximate Power and Sample Size Determination for Common one-Sample and two-Sample Hypothesis Tests , 1970 .
[2] J. Fleiss. Statistical methods for rates and proportions , 1974 .
[3] P. Leber. Hazards of Inference: The Active Control Investigation , 1989, Epilepsia.
[4] D L DeMets,et al. Monitoring of clinical trials: issues and recommendations. , 1993, Controlled clinical trials.
[5] The call of the sirens. Navigating the ethics of medication-free research in schizophrenia. , 1997, Archives of general psychiatry.
[6] D. Linszen,et al. Early intervention, untreated psychosis and the course of early schizophrenia , 1998, British Journal of Psychiatry.
[7] P W Lavori,et al. Developing and comparing treatment strategies: an annotated portfolio of designs. , 1998, Psychopharmacology bulletin.
[8] J. Calabrese,et al. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. , 1999, The American journal of psychiatry.
[9] S. Ellenberg,et al. Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 2: Practical Issues and Specific Cases , 2000, Annals of Internal Medicine.
[10] H. Sung,et al. Evaluating multiple treatment courses in clinical trials. , 2000, Statistics in medicine.
[11] R. Drake,et al. Causes and consequences of duration of untreated psychosis in schizophrenia. , 2000, The British journal of psychiatry : the journal of mental science.
[12] K. Kendler,et al. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the "kindling" hypothesis. , 2000, The American journal of psychiatry.
[13] Ree Dawson,et al. Flexible treatment strategies in chronic disease: clinical and research implications , 2000, Biological Psychiatry.
[14] S S Ellenberg,et al. Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific Issues , 2000, Annals of Internal Medicine.
[15] P. Lavori. Placebo control groups in randomized treatment trials: a statistician’s perspective , 2000, Biological Psychiatry.
[16] S. Wellek. On a reasonable disaggregate criterion of population bioequivalence admitting of resampling-free testing procedures. , 2000, Statistics in medicine.
[17] J M Robins,et al. Marginal Mean Models for Dynamic Regimes , 2001, Journal of the American Statistical Association.
[18] R. D'Agostino,et al. Non‐inferiority trials: design concepts and issues – the encounters of academic consultants in statistics , 2002, Statistics in medicine.
[19] Yi Tsong,et al. Some fundamental issues with non‐inferiority testing in active controlled trials , 2002, Statistics in medicine.
[20] P. Lavori,et al. Comparison of designs for adaptive treatment strategies: baseline vs. adaptive randomization , 2003 .